Cytokine storms: understanding COVID-19

Cited by (703)

Items 101–200 of 703

1. Effects of donkey milk on oxidative stress and inflammatory response
   Yan Li, Qingshan Ma, Guiqin Liu, Changfa Wang · 2021 · Journal of Food Biochemistry
2. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
   Janhavi Prasad Natekar, Heather Pathak, Shannon Stone, Pratima Kumari, Shaligram Sharma, Tabassum Tasnim Auroni, Komal Arora, Hussin A. Rothan, Mukesh Kumar · 2022 · Viruses
3. Circulating microRNAs as emerging regulators of COVID-19
   Yulong Liang, Dan Fang, Xiaojun Gao, Xin Deng, Ni Chen, Jianbo Wu, Min De ZENG, Mao Luo · 2022 · Theranostics
4. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
   Guoli Shi, Abhilash I. Chiramel, Tiansheng Li, Kin Kui Lai, Adam D. Kenney, Ashley Zani, Adrian C. Eddy, Saliha Majdoul, Lizhi Zhang, Tirhas Dempsey et al. · 2022 · Journal of Clinical Investigation
5. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
   Roberto Littera, Luchino Chessa, Silvia Deidda, Goffredo Angioni, Marcello Campagna, Sara Lai, Maurizio Melis, Selene Cipri, Davide Firinu, Simonetta Santus et al. · 2021 · PLoS ONE
6. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity
   Yuehui Zhang, Limin Shang, Jing Zhang, Yuchen Liu, Chaozhi Jin, Yanan Zhao, Xiaobo Lei, Wenjing Wang, Xia Xiao, Xiuyuan Zhang et al. · 2021 · Cell chemical biology
7. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
   Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossainpour, Amirhooshang Alvandi, Jale Moradi, Ramin Abiri · 2021 · International Immunopharmacology
8. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections
   Maximilian Hirschenberger, Victoria Hunszinger, Konstantin M. J. Sparrer · 2021 · Cells
9. Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge
   Christine H. Meyer‐Frießem, Janne Gierthmühlen, Ralf Baron, Claudia Sommer, Nurcan Üçeyler, Elena Enax‐Krumova · 2021 · PAIN Reports
10. Persistent Lung Injury and Prothrombotic State in Long COVID
    Mengqi Xiang, Haijiao Jing, Chengyue Wang, Valerie Anne Novakovic, Jialan Shi · 2022 · Frontiers in Immunology
11. Current evidence on the use of anakinra in COVID-19
    Elnaz Khani, Marzieh Shahrabi, Haleh Rezaei, Fariba Pourkarim, Hoda Afsharirad, Mohammad Solduzian · 2022 · International Immunopharmacology
12. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
    Ayat Zawawi, Abdallah Y. Naser, Hassan H Alwafi, Faisal Minshawi · 2021 · Frontiers in Immunology
13. Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19
    Fang Sun, Chenglin Mu, Hang Fai Kwok, Jiyuan Xu, Yingliang Wu, Wanhong Liu, Jean‐Marc Sabatier, Cédric Annweiler, Xugang Li, Zhijian Cao et al. · 2021 · International Journal of Biological Sciences
14. Basic virology of SARS-CoV 2
    Varun Ravi, Sonal Saxena, Pragyan Swagatika Panda · 2022 · Indian Journal of Medical Microbiology
15. Bioengineered Neutrophil Extinguisher Targets Cascade Immune Pathways of Macrophages for Alleviating Cytokine Storm in Pneumonia
    Anwei Zhou, Kerong Chen, Ya Gao, Xinyuan Zhou, Zihan Tian, Weiwei Chen, Yurui Xu, Zhuo Chen, Xinghai Ning · 2023 · ACS Nano
16. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
    Yang Li, Zhaowei Xu, Qing Lei, Dan‐yun Lai, Hongyan Hou, He‐wei Jiang, Yun-xiao Zheng, Xuening Wang, Jiaoxiang Wu, Ming‐liang Ma et al. · 2021 · Cell Reports
17. Altered platelet and coagulation function in moderate-to-severe COVID-19
    Литвинов Рустем Игоревич, Natalia G. Evtugina, Alina D. Peshkova, Svetlana I. Safiullina, Izabella A. Andrianova, Alina I. Khabirova, Chandrasekaran Nagaswami, Хисматуллин Рафаэль Рафикович, Svetlana S. Sannikova, John W. Weisel · 2021 · Scientific Reports
18. COVID-19 Disease and Dermatomyositis: A Mini-Review
    Jie Qian, Hui Xu · 2022 · Frontiers in Immunology
19. Vascular endothelial-derived SPARCL1 exacerbates viral pneumonia through pro-inflammatory macrophage activation
    Gan Zhao, Maria Elena Gentile, Lulu Xue, Christopher V. Cosgriff, Aaron I. Weiner, Stephanie Adams‐Tzivelekidis, Joanna Wong, Xinyuan Li, Sara Kass-Gergi, Nicolas P. Holcomb et al. · 2024 · Nature Communications
20. The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review
    Felix Scholkmann, Tanja Restin, Marco Ferrari, Valentina Quaresima · 2020 · Journal of Clinical Medicine
21. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
    Anita Gupta, Gopal S. Gupta · 2021 · Molecular and Cellular Biochemistry
22. Mortality in critically ill patients with coronavirus disease 2019‐associated pulmonary aspergillosis: A systematic review and meta‐analysis
    Shreya Singh, Nipun Verma, Rimjhim Kanaujia, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy · 2021 · Mycoses
23. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
    Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, Qi Zhang, Lingzhi Fan, Yangxin Fang, Yifei Li, Charlie Xiang · 2022 · Cellular and Molecular Life Sciences
24. Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
    Acharya Balkrishna, Swati Haldar, Hoshiyar Singh, Partha Roy, Anurag Varshney · 2021 · Journal of Inflammation Research
25. Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential.
    F. B. Felix, J. Vago, V. A. Beltrami, J. M. D. Araújo, R. Grespan, M. M. Teixeira, V. Pinho · 2022 · Pharmacological Research
26. Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome
    Eduardo Huarte, Michael T. Peel, Katherine Verbist, Brittany L. Fay, Rachel Bassett, Sabrin Albeituni, Kim E. Nichols, Paul A. Smith · 2021 · Frontiers in Pharmacology
27. Transition Metal‐Based Therapies for Inflammatory Diseases
    Yilin Song, Qing You, Xiaoyuan Shawn Chen · 2023 · Advanced Materials
28. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
    Argus Sun, Tyler Hoffman, Bao Q. Luu, Nureddin A. Ashammakhi, Song Li · 2021 · Bio-Design and Manufacturing
29. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review
    Sara Tomerak, Safah Khan, Muna Almasri, Rawan Hussein, Ali A. Abdelati, Ahmed Mohamed Aly, Mohammad A. Salameh, Arwa Saed Aldien, Hiba Naveed, Mohamed Badreldin Elshazly et al. · 2021 · Scandinavian Journal of Immunology
30. The role of antirheumatics in patients with COVID-19
    Christoffer B Nissen, Savino Sciascia, DANIELI CASTRO OLIVEIRA DE ANDRADE, Tatsuya Atsumi, Ian N Bruce, Randy Quentin Cron, Oliver Hendricks, Dario Roccatello, Ksenija Stach, Mattia Trunfio et al. · 2021 · The Lancet Rheumatology
31. A meta-analysis of impacts of immune response and infection on oxidative status in vertebrates
    David Costantini · 2022 · Conservation Physiology
32. Cytokine Storm Modulation in COVID-19: A Proposed Role for Vitamin D and DPP-4 Inhibitor Combination Therapy (VIDPP-4i)
    Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante · 2021 · Immunotherapy
33. Interstitial pneumonia and diffuse alveolar damage in domestic animals
    Francisco R. Carvallo, Valentina B. Stevenson · 2022 · Veterinary Pathology
34. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
    Vijay Kumar · 2020 · International Immunopharmacology
35. Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
    Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra, Besim Öğretmen · 2021 · Scientific Reports
36. Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
    Lili Yu, Xiaoying Zhang, Sarah Ye, Hongkai Lian, Hui Wang, Jianping Ye · 2022 · The Journal of Clinical Endocrinology & Metabolism
37. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
    Donovan Anthony McGrowder, Fabian G. Miller, Melisa Anderson Cross, Lennox Anderson-Jackson, Sophia Bryan, Lowell Dilworth · 2021 · Diseases
38. Vimentin as a target for the treatment of COVID-19
    Zhenlin Li, Denise Paulin, Patrick J. Lacolley, Dario Coletti, Onnik Agbulut · 2020 · BMJ Open Respiratory Research
39. The Impact of COVID-19 on Liver Injury
    Reham Mohammed Dawood, Ghada Maher Salum, Mai Abd El-Meguid · 2021 · The American Journal of the Medical Sciences
40. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection
    Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik, Milana Frenkel‐Morgenstern · 2021 · Viruses
41. Leptin receptor signaling sustains metabolic fitness of alveolar macrophages to attenuate pulmonary inflammation
    Ziyi Guo, Haoqi Yang, Jing‐Ren Zhang, Wenwen Zeng, Xiaoyu Hu · 2022 · Science Advances
42. Coronavirus disease 2019 (COVID-19) and autoimmunity
    Evgeny Lvovich Nasonov · 2021 · Rheumatology Science and Practice
43. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
    Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning · 2021 · Frontiers in Immunology
44. Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19
    Ashim Gupta, Shivaji Kashte, Sachin S. Kadam, Manu Gupta, Hugo C. Rodriguez, Anish G. R. Potty, Saadiq F. El‐Amin, Nicola Maffulli · 2021 · Expert Opinion on Biological Therapy
45. Circulating Polyunsaturated Fatty Acids and COVID-19: A Prospective Cohort Study and Mendelian Randomization Analysis
    Yitang Sun, Radhika Chatterjee, Akash Ronanki, Kaixiong Ye · 2022 · Frontiers in Medicine
46. Human genetic basis of coronavirus disease 2019
    H. Deng, Xue Yan, La-Mei Yuan · 2021 · Signal Transduction and Targeted Therapy
47. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome
    Peixian Chen, Yan Tang, Weixin He, Ruixuan Yang, Zhien Lan, Ruirong Chen, Peidong Zhang · 2022 · Mediators of Inflammation
48. Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study
    Mai Mostafa Aly, Taghreed Sayed Meshref, Marwa Ahmed Abdelhameid, Shimaa Abdallah Ahmed, Asmaa S. Shaltout, Alaa Eldin Abdel-Moniem, Dina Ali Hamad · 2021 · Journal of Blood Medicine
49. Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung
    Cameron Bishop, Kexin Yan, Wilson Nguyen, Daniel J. Rawle, Bing Tang, Thibaut Larcher, Andreas Suhrbier · 2024 · Frontiers in Immunology
50. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways
    Hussin A. Rothan, Pratima Kumari, Shannon Stone, Janhavi Prasad Natekar, Komal Arora, Tabassum Tasnim Auroni, Mukesh Kumar · 2022 · Pathogens
51. SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes
    Fa‐Min Zeng, Ying‐wen Li, Zhao‐hua Deng, Jianzhong He, Wei Li, Lijie Wang, Ting Lyu, Zhanyu Li, Chaoming Mei, Meiling Yang et al. · 2022 · EMBO Molecular Medicine
52. Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest
    Wenjing Wu, Wenbiao Wang, Liying Liang, Junzhe Chen, Biao Wei, Xiao‐Ru Huang, Xiaoqin Wang, Xueqing Yu, Hui Y. Lan · 2022 · Molecular Therapy
53. Fullerene‐Based Immunoregulatory Nanomaterials for Immunotherapy of Tumor and Immune‐Related Inflammatory Diseases
    Mingming Zhen, Yuan Ming Xu, Chunru Wang, Chunli Bai · 2024 · Advanced Functional Materials
54. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries
    Li Ni, Linwen Zhu, Lebo Sun, Guofeng Shao · 2021 · Stem Cell Research
55. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy
    Shirin Kouhpayeh, Laleh Shariati, Maryam Boshtam, Ilnaz Rahimmanesh, Mina Mirian, Yasaman Esmaeili, Malihe Najaflu, Negar Khanahmad, Mehrdad Zeinalian, Maria Trovato et al. · 2021 · International Journal of Molecular Sciences
56. The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review
    Claudio Brasso, Silvio Bellino, Cecilia Blua, Paola Bozzatello, Paola Rocca · 2022 · Biomedicines
57. Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin
    Claudio Costantini, Frank L. van de Veerdonk, Luigina R. Romani · 2020 · Vaccines
58. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis
    Benedicto Crespo‐Facorro, Miguel Ruíz-Veguilla, Javier Vázquez-Bourgón, Ana C. Sánchez-Hidalgo, Nathalia Garrido Torres, José Miguel Cisneros, Carlos Alberto Vanegas Prieto, Jesús Sainz · 2021 · Frontiers in Pharmacology
59. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
    Adonis Sfera, C. Osorio, Carlos M. Zapata Martín del Campo, Shaniah Pereida, S. Maurer, J. C. Maldonado, Z. Kozlakidis · 2021 · Frontiers in Cellular Neuroscience
60. Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
    Laura Marongiu, Giulia Protti, Fabio Alessandro Facchini, Mihai Valache, Francesca Mingozzi, Valeria Ranzani, Anna Rita Putignano, Lorenzo Salviati, Valeria Bevilacqua, Serena Curti et al. · 2021 · European Journal of Immunology
61. The critical impacts of cytokine storms in respiratory disorders
    Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya Khursheed, Sofi Imtiyaz Ali, Naveed Nazir Shah, Syed Taifa, Rabia Rakhshan, Iqra Hussain Shah, Muzafar Ahmad Mir, Masood Malik et al. · 2024 · Heliyon
62. Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure
    Hilal Hachem, Amandeep Godara, Courtney Schroeder, Daniel E.C. Fein, Hashim Mann, Christian Lawlor, Jill Marshall, Andreas K. Klein, Debra D. Poutsiaka, Janis L. Breeze et al. · 2021 · Journal of Clinical and Translational Science
63. Severity of SARS-CoV-2 infection is linked to double-negative (CD27− IgD−) B cell subset numbers
    Rodrigo Cervantes‐Díaz, Víctor A. Sosa‐Hernández, Jiram José Torres-Ruiz, Sandra Romero‐Ramírez, Mariana Cañez-Hernández, Alfredo Pérez‐Fragoso, José C. Páez-Franco, David Eduardo Meza-Sánchez, Miriam Pescador‐Rojas, Víctor Adrián Sosa-Hernández et al. · 2021 · Inflammation Research
64. SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice
    Shannon Stone, Hussin A. Rothan, Janhavi Prasad Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak, Komal Arora, Tabassum Tasnim Auroni, Mukesh Kumar · 2021 · Viruses
65. Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
    Swati Bhat, P. Rishi, V. Chadha · 2022 · Virus Research
66. Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
    Claudio Tirelli, Mara DE AMICI, Cristina Albrici, Sabrina Mira, Giulia Nalesso, Beatrice Re, Angelo Guido Corsico, Michele Mondoni, Stefano Centanni · 2023 · Biology
67. The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm: A Randomized Clinical Trial in Adults with Vitamin D Deficiency
    Dana A. Bader, Anas Ibrahim Abed, Beisan Ali Mohammad, Ahmad Aljaberi, Ahmad Sundookah, Maha Habash, Ahmad Riyad Alsayed, Mohammad Abusamak, Sami Al-Shakhshir, Mahmoud Abu-Samak · 2023 · Nutrients
68. Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?
    Florian Moretto, Thibault Sixt, H. Devilliers, Maroua Abdallahoui, Isabelle Eberl, Thomas Rogier, M. Buisson, P. Chavanet, Michel Duong, Clémentine Estève et al. · 2021 · International Journal of Infectious Diseases
69. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection
    Luana Meller Manosso, Camila Orlandi Arent, Laura A. Borba, Luciane Bisognin Ceretta, João Quevedo, Gislaine Z. Réus · 2021 · Cells
70. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
    Julie C. F. Rappe, Katja Finsterbusch, Stefania Crotta, Matthias Mack, Simon Lawrence Priestnall, Andreas Wack · 2021 · The Journal of Experimental Medicine
71. The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis
    Xueyang Zhang, Lianhan Shang, Guohui Fan, Xiaoying Gu, Jiuyang Xu, Yeming Wang, Lixue Huang, Bin Cao · 2022 · Frontiers in Medicine
72. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future
    Yukai Wang, Guangzhou Du, Guohong Zhang, Marco Matucci‐Cerinic, Daniel E. Furst · 2020 · Annals of the Rheumatic Diseases
73. Association between vitamin D status and risk of covid-19 in-hospital mortality: A systematic review and meta-analysis of observational studies
    Armin Ebrahimzadeh, Shokouh Mohseni, Behnaz Narimani, Anahita Ebrahimzadeh, Soroosh Kazemi, Fatemeh Keshavarz, Mohammad Javad Yaghoubi, Alireza Milajerdi · 2021 · Critical Reviews in Food Science and Nutrition
74. Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?
    Federica Saponaro, Maria Franzini, Chukwuma Okoye, Rachele Antognoli, Beatrice Campi, Marco Scalese, Tommaso Neri, Laura Carrozzi, Fabio Monzani, Riccardo Zucchi et al. · 2022 · Frontiers in Immunology
75. Research progress on the prevention of tumor by fungal polysaccharides
    Wenbin Yu, Yufei Zhang, Lihua Yao, Jiahua Peng, Yayi Tu, Bin He · 2024 · Trends in Food Science & Technology
76. BCG vaccination early in life does not improve COVID‐19 outcome of elderly populations, based on nationally reported data
    Trudy M. Wassenaar, Gregory S. Buzard, David J. Newman · 2020 · Letters in Applied Microbiology
77. Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19
    Jie Geng, Feng Wang, Zhiwei Huang, Xiaobo Chen, Yuliang Wang · 2021 · Cytokine
78. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case–control study of COVID-19 patients
    Jalal Moludi, Shaimaa A. Qaisar, Mohammad Alizadeh, Hamed Jafari Vayghan, Mohammad Naemi, Akram Rahimi, Rihaneh Mousavi · 2021 · British Journal Of Nutrition
79. Vitamin D and COVID ‐19: A review on the role of vitamin D in preventing and reducing the severity of COVID ‐19 infection
    Mobeen Abdrabbo, Cole M. Birch, Michael Brandt, Kelsey A. Cicigoi, Stephen J. Coffey, Connor C. Dolan, Hannah Dvorak, Ava C. Gehrke, Audrey E. L. Gerzema, Abby Hansen et al. · 2021 · Protein Science
80. Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology
    Rasmus Rydbirk, Ole Østergaard, Jonas Folke, Casper Hempel, Brian DellaValle, Thomas Lars Andresen, Annemette Løkkegaard, Anne‐Mette Hejl, Matthias Bode, Morten Blaabjerg et al. · 2022 · Cellular and Molecular Life Sciences
81. The disruptive role of LRG1 on the vasculature and perivascular microenvironment
    A. Dritsoula, C. Camilli, Stephen E. Moss, J. Greenwood · 2024 · Frontiers in Cardiovascular Medicine
82. Roles of cytokine storm in sepsis progression: biomarkers, and emerging therapeutic strategies
    Weibin You · 2025 · Frontiers in Immunology
83. Safety and efficacy of a COVID‑19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open‑label, controlled trial
    Iván Delgado‐Enciso, Juan Paz-García, Carlos E Barajas-Saucedo, Karen A Mokay-Ramírez, Carmen Meza‐Robles, Rodrigo Lopez‐Flores, Marina Delgado‐Machuca, Efrén Murillo‐Zamora, Jose A. Toscano-Velazquez, Josuel Delgado‐Enciso et al. · 2021 · Experimental and Therapeutic Medicine
84. Covid-19 interface with drug misuse and substance use disorders
    Irma E. Cisneros, Kathryn A. Cunningham · 2021 · Neuropharmacology
85. Cytokine profile in Egyptian children and adolescents with COVID‐19 pneumonia: A multicenter study
    Hala K. Shafiek, Hanan Mohamed Abd El Lateef, Naglaa F Boraey, Mohamed Nashat, Ghada A. B. Abd‐Elrehim, Heba Abouzeid, Sahbaa Fehr Mohamed Hafez, Hassan Shehata, Ahmed Elhewala, Alsayed Abdel‐Aziz et al. · 2021 · Pediatric Pulmonology
86. Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review
    Reem Hanna, Snehal Dalvi, Tudor Sălăgean, Ioana Roxana Bordea, Stefano Benedicenti · 2020 · Antioxidants
87. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
    Esperanza Martín‐Sánchez, Juan‐José Garcés, Catarina Maia, Susana Inogés, Ascensión López-Dı́az de Cerio, Francisco Carmona-Torre, Marta Marín‐Oto, Félix Alegre, Elvira Molano, Mirian Fernández-Alonso et al. · 2021 · Frontiers in Immunology
88. COVID-19 in Children
    Meena Kalyanaraman, Michael R. Anderson · 2022 · Pediatric Clinics of North America
89. Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
    David R. Price, Elisa Benedetti, Katherine L. Hoffman, Luis G. Gómez-Escobar, Sergio L. Alvarez-Mulett, Allyson M. Capili, Hina Sarwath, Christopher N. Parkhurst, Elyse LaFond, Karissa Weidman et al. · 2022 · American Journal Of Pathology
90. Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report
    Narendra Nath Khanna, Mahesh A. Maindarkar, Anudeep Puvvula, Sudip Paul, Mrinalini Bhagawati, Puneet Ahluwalia, Zoltán Ruzsa, Aditya Sharma, Smiksha Munjral, Raghu Kolluri et al. · 2022 · Journal of Cardiovascular Development and Disease
91. Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19
    Yingying Lü, Feng Liu, Gangling Tong, Feng Qiu, Pinhong Song, Xiaolin Wang, Xiafei Zou, Deyun Wan, Miao Cui, Yunsheng Xu et al. · 2021 · Signal Transduction and Targeted Therapy
92. Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8+ T cells in COVID-19
    Lei He, Quan Zhang, Yue Zhang, Yixian Fan, Fahu Yuan, Songming Li · 2021 · Cell Communication and Signaling
93. Roles of the gut microbiota in severe SARS-CoV-2 infection
    Yiran Liu, Dan Kuang, Dan Li, Ju Yang, Jiai Yan, Yanping Xia, Feng Zhang, Hong Cao · 2022 · Cytokine & Growth Factor Reviews
94. New-onset dermatomyositis following COVID-19: A case report
    Hiroshi Shimizu, Haruki Matsumoto, Tomomi Sasajima, Tomohiro Suzuki, Yoshinori Okubo, Yuya Fujita, Jumpei Temmoku, Shuhei Yoshida, Tomoyuki Asano, Hiromasa Ohira et al. · 2022 · Frontiers in Immunology
95. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity
    Anat Aharon, Ayelet Dangot, Fadi Kinaani, Mor Zavaro, Lian Bannon, Tali Hana Bar-Lev, Anat Keren‐Politansky, Irit Mazza Avivi, Giris Jacob · 2023 · International Journal of Molecular Sciences
96. The Emerging Role of Ferroptosis in Sepsis, Opportunity or Challenge?
    Qigang Huang, Yingwei Ding, Chao Fang, Hao Wang, Laifa Kong · 2023 · Infection and Drug Resistance
97. The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage
    Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang · 2021 · Bioscience Reports
98. Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions
    Yujiro Matsuishi, Bryan James Mathis, Nobutake Shimojo, Jesmin Subrina, Nobuko Okubo, Yoshiaki Inoue · 2021 · Biomedicines
99. Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19)
    Yexiao Tang, Xiaobo Li, Yueming Yuan, Hongying Zhang, Yuanyuan Zou, Zhiyong Xu, Qin Xu, Jianping Song, Changsheng Deng, Qi Wang · 2022 · BMC Complementary Medicine and Therapies
100. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses
     Masako Kohyama, Tatsuya Suzuki, Wataru Nakai, Chikako Ono, Sumiko Matsuoka, Koichi Iwatani, Yafei Liu, Yusuke Sakai, Atsushi Nakagawa, Keisuke Tomii et al. · 2022 · International Immunology